IDNNA

This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help by introducing citations to additional sources. Find sources:  –  ·  ·  · scholar · JSTOR (October 2019)

IDNNA

Names
Preferred IUPAC name 1-(4-Iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
Other names 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine 2,5-Dimethoxy-4-iodo-1-ethyl-(α-methyl)amine
Identifiers
CAS Number	85563-10-6 Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL11043 Y
ChemSpider	119009 Y
PubChem CID	135056
CompTox Dashboard (EPA)	DTXSID901006121
InChI InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Y Key: XBCUSBRGRALQID-UHFFFAOYSA-N Y InChI=1/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYAY
SMILES Ic1cc(OC)c(cc1OC)CC(N(C)C)C
Properties
Chemical formula	C13H20NO2I
Molar mass	349.211 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Y  (what is YN ?)
Infobox references

IDNNA (2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 2.6 mg, and the duration unknown.^[1] IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Legality[]

United Kingdom[]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

See also[]

• Phenethylamine
• Psychedelics, dissociatives and deliriants

References[]

This psychoactive drug-related article is a stub. You can help Wikipedia by .

• v
• t